Marijuana is becoming increasingly accepted as a legitimate medical treatment and research subject in the U.S. Federal policy changes in 2026 are making it easier for researchers and licensed medical-marijuana businesses to operate, potentially accelerating studies into cannabis-based treatments. That could lead to more reliable cannabis medicines and clearer guidance for patients.
Another encouraging development is that more jurisdictions continue to recognize marijuana's medical and therapeutic potential, giving patients legal access to cannabis products for conditions such as chronic pain, chemotherapy-related nausea, and certain forms of seizure disorders. The broader shift away from treating cannabis solely as an illicit drug and toward treating it as a potential medicine could mean more research, better-regulated products, and greater access for patients who benefit from it.
More young people are also using marijuana, and some are increasingly turning to concentrated forms such as dabbing. Dabbing involves using cannabis concentrates that contain much higher levels of THC than traditional marijuana. The growing popularity of dabbing among young people reflects how cannabis products and methods of consumption are changing, particularly with the rise of highly concentrated products.